Bruni J V & Co. Co. bought a new stake in NICE Ltd. (NASDAQ:NICE - Free Report) during the third quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor bought 131,568 shares of the technology company's stock, valued at approximately $22,849,000. NICE makes up 2.5% of Bruni J V & Co. Co.'s investment portfolio, making the stock its 20th biggest position. Bruni J V & Co. Co. owned approximately 0.21% of NICE as of its most recent filing with the SEC.
Several other large investors have also modified their holdings of NICE. Vulcan Value Partners LLC lifted its holdings in NICE by 49.7% during the 2nd quarter. Vulcan Value Partners LLC now owns 1,188,371 shares of the technology company's stock worth $204,168,000 after buying an additional 394,715 shares during the last quarter. Migdal Insurance & Financial Holdings Ltd. raised its holdings in shares of NICE by 21.6% during the third quarter. Migdal Insurance & Financial Holdings Ltd. now owns 1,575,645 shares of the technology company's stock worth $273,642,000 after purchasing an additional 279,375 shares during the period. Acadian Asset Management LLC lifted its position in shares of NICE by 63.2% in the 2nd quarter. Acadian Asset Management LLC now owns 694,050 shares of the technology company's stock worth $119,317,000 after buying an additional 268,677 shares during the last quarter. Marshall Wace LLP bought a new stake in shares of NICE during the 2nd quarter valued at about $44,076,000. Finally, Black Creek Investment Management Inc. boosted its stake in NICE by 22.6% in the second quarter. Black Creek Investment Management Inc. now owns 1,356,775 shares of the technology company's stock valued at $233,325,000 after acquiring an additional 250,334 shares during the period. Institutional investors own 63.34% of the company's stock.
Shares of NICE stock opened at $173.83 on Tuesday. NICE Ltd. has a 12-month low of $151.52 and a 12-month high of $270.73. The stock has a market capitalization of $10.93 billion, a P/E ratio of 26.91, a PEG ratio of 1.39 and a beta of 1.04. The stock has a 50 day moving average price of $173.17 and a two-hundred day moving average price of $177.40.
Several brokerages recently issued reports on NICE. Barclays cut their price target on NICE from $320.00 to $286.00 and set an "overweight" rating on the stock in a report on Thursday, July 25th. Northland Securities reduced their price target on shares of NICE from $275.00 to $250.00 and set an "outperform" rating for the company in a report on Friday. JMP Securities reaffirmed a "market outperform" rating and issued a $300.00 price objective on shares of NICE in a report on Friday, August 16th. Jefferies Financial Group dropped their price target on shares of NICE from $230.00 to $215.00 and set a "buy" rating on the stock in a research note on Friday. Finally, Citigroup boosted their price objective on NICE from $330.00 to $334.00 and gave the stock a "buy" rating in a research report on Wednesday, November 13th. Two investment analysts have rated the stock with a hold rating and fourteen have given a buy rating to the company. According to MarketBeat.com, the stock has an average rating of "Moderate Buy" and a consensus target price of $260.57.
View Our Latest Analysis on NICE
NICE Ltd., together with its subsidiaries, provides cloud platforms for AI-driven digital business solutions worldwide. It offers CXone, a cloud native open platform; Enlighten, an AI engine for the customer engagement market; and smart self service enable organizations to address consumers' needs; and journey orchestration solutions that empower organizations to connect and route customers to deal with the customer's request, and connects them using real time AI-based routing.
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to [email protected].
Before you consider NICE, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and NICE wasn't on the list.
While NICE currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.